ACTIVIT (DOCTORS PRESCRIBED): A CLINICALLY OPTIMIZED, METHYLATED MULTIVITAMIN FOR SUPERIOR MICRONUTRIENT BIOAVAILABILITY AND FUNCTIONAL HEALTH

Abstract

Micronutrient deficiencies remain a pervasive global health concern despite widespread use of multivitamin supplements. Emerging evidence suggests that persistent deficiencies are driven not only by inadequate intake but also by declining nutrient density of food, impaired gastrointestinal absorption, increased physiological demand, pharmaceutical interference, and genetic polymorphisms affecting nutrient metabolism. Conventional multivitamin formulations frequently rely on synthetic vitamin forms and inorganic mineral salts, which may demonstrate limited bioavailability and metabolic utilization. In particular, reduced activity of the methylenetetrahydrofolate reductase (MTHFR) enzyme compromises folate metabolism and methylation capacity in a substantial proportion of the population.

The present randomized, double-blind, controlled experimental study evaluated ACTIVIT (Doctors Prescribed), a clinically optimized multivitamin containing methylated B-vitamins and amino acid–chelated minerals, for its effects on micronutrient bioavailability and functional health outcomes. One hundred twenty healthy adults were randomized to receive either ACTIVIT (Doctors Prescribed) (n = 60) or a conventional multivitamin (n = 60) for 12 weeks. Primary outcomes included serum vitamin B12, red blood cell (RBC) folate, plasma homocysteine, serum magnesium, and zinc. Secondary outcomes included fatigue severity scores.

ACTIVIT(Doctors Prescribed) supplementation resulted in significantly greater increases in serum B12 (↑42.6%, p < 0.001) and RBC folate (↑38.2%, p < 0.001), along with a significant reduction in plasma homocysteine (−21.4%, p < 0.001) compared with controls. Chelated mineral delivery produced higher serum magnesium (↑19.3%, p = 0.002) and zinc levels (↑17.8%, p = 0.004). Participants receiving ACTIVIT also demonstrated a marked improvement in fatigue severity scores (−31.6%, p < 0.001). These findings support the clinical relevance of bioactive vitamin forms and chelated minerals for addressing modern micronutrient insufficiency.